Croda Discloses Executive Share Award Exercise and Related Share Sales

Croda International ( (GB:CRDA) ) has issued an update.

Croda International has disclosed a share transaction involving company secretary Thomas Michael Brophy, a person discharging managerial responsibilities. Brophy exercised conditional awards under the company’s Performance Share Plan and Deferred Bonus Share Plan, receiving ordinary shares at nil cost.

To meet associated tax liabilities, Brophy sold a portion of these shares on the London Stock Exchange at £26.057 per share. The notification underscores routine governance and transparency requirements around executive share-based remuneration rather than signaling a strategic shift in the company’s operations or outlook.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £2917.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Spark’s Take on CRDA Stock

According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.

The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).

To see Spark’s full report on CRDA stock, click here.

More about Croda International

Croda International Plc is a U.K.-based specialty chemicals company that develops and supplies high-performance ingredients and technologies. Its products serve markets including personal care, life sciences, crop protection, and industrial applications, with a focus on innovative, sustainable solutions for global manufacturers.

Average Trading Volume: 560,821

Technical Sentiment Signal: Strong Sell

Current Market Cap: £3.7B

For an in-depth examination of CRDA stock, go to TipRanks’ Overview page.